News & Insights
Sort By
Client News 13 Results
Client News
|October 21, 2026
Gunderson Dettmer represented Jefferies, Leerink Partners, and TD Cowen as representatives of the underwriters in the common stock offering of Arcus Biosciences (NYSE:RCUS), a late clinical-stage biopharmaceutical company focused on developing differentiated molecules and combinations for the treatment of cancer and immune diseases.
Client News
|June 4, 2026
Gunderson Dettmer Advises Aeva on $115 Million Follow-On Offering
Aeva Technologies, Inc., a leader in next-generation sensing and perception systems, announces its $115.0 million public offering.
Client News
|May 18, 2026
Gunderson Dettmer Represents Hims & Hers in Upsized $402.5 Million Convertible Senior Notes Offering
Gunderson Dettmer advised Hims & Hers (NYSE: HIMS) in its offering of $402.5 million aggregate principal amount of 0.00% convertible senior notes due 2032.